According to the latest report “ELISpot and FluoroSpot Assay Market by Product (Assay Kit (T Cell and B Cell assay), Analyzer, Ancillary Products), Application (Transplant, Vaccines, Clinical Trials, Cancer), End User (Hospital, Labs, Research Institute) - Global Forecast to 2023”
The ELISpot and FluoroSpot market is projected to reach USD 287 million by 2023 from USD 135 million in 2018, at a CAGR of 16.2% during the forecast period.
Download a FREE Pdf Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=124350584
The study involved four major activities to estimate the current market size for the ELISpot and FluoroSpot market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.
Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for this study.
Primary Research
Several stakeholders such as ELISpot and FluoroSpot equipment manufacturers, vendors, and distributors and scientists, researchers, laboratory technicians, and doctors from hospitals and clinics were consulted for this report. The demand side of this market is characterized by significant use of ELISpot and FluoroSpot assay kits and instruments due to increasing chronic diseases and vaccine development across the globe. The supply side is characterized by advancements in technology. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.
Key Market Players
Some of the prominent players in the ELISpot and FluoroSpot are Oxford Immunotec (UK), Cellular Technologies (US), Mabtech (Sweden), Becton, Dickinson and Company (US), and Abcam (UK). Read More
The ELISpot and FluoroSpot market is projected to reach USD 287 million by 2023 from USD 135 million in 2018, at a CAGR of 16.2% during the forecast period.
Download a FREE Pdf Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=124350584
The study involved four major activities to estimate the current market size for the ELISpot and FluoroSpot market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.
Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for this study.
Primary Research
Several stakeholders such as ELISpot and FluoroSpot equipment manufacturers, vendors, and distributors and scientists, researchers, laboratory technicians, and doctors from hospitals and clinics were consulted for this report. The demand side of this market is characterized by significant use of ELISpot and FluoroSpot assay kits and instruments due to increasing chronic diseases and vaccine development across the globe. The supply side is characterized by advancements in technology. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.
Key Market Players
Some of the prominent players in the ELISpot and FluoroSpot are Oxford Immunotec (UK), Cellular Technologies (US), Mabtech (Sweden), Becton, Dickinson and Company (US), and Abcam (UK). Read More
Comments
Post a Comment